Northwest Biotherapeutics Statistics
Total Valuation
NWBO has a market cap or net worth of $606.88 million. The enterprise value is $636.99 million.
| Market Cap | 606.88M |
| Enterprise Value | 636.99M |
Important Dates
The last earnings date was Tuesday, February 28, 2023.
| Earnings Date | Feb 28, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
NWBO has 1.19 billion shares outstanding. The number of shares has increased by 7.74% in one year.
| Shares Outstanding | 1.19B |
| Shares Change (YoY) | +7.74% |
| Shares Change (QoQ) | +1.47% |
| Owned by Insiders (%) | 10.04% |
| Owned by Institutions (%) | 0.25% |
| Float | 1.11B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 307.22 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 329.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 130.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -222.69% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $77,280 |
| Profits Per Employee | -$2.49M |
| Employee Count | 25 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NWBO has paid $22,000 in taxes.
| Income Tax | 22,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.56% in the last 52 weeks. The beta is -0.70, so NWBO's price volatility has been lower than the market average.
| Beta (1Y) | -0.70 |
| 52-Week Price Change | -7.56% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 44.35 |
| Average Volume (30 Days) | 1,730,527 |
Short Selling Information
The latest short interest is 14.14 million, so 1.19% of the outstanding shares have been sold short.
| Short Interest | 14.14M |
| Short Previous Month | 13.83M |
| Short % of Shares Out | 1.19% |
| Short % of Float | 1.28% |
| Short Ratio (days to cover) | 13.54 |
Income Statement
In the last 12 months, NWBO had revenue of $1.93 million and -$62.23 million in losses. Loss per share was -$0.06.
| Revenue | 1.93M |
| Gross Profit | 199,000 |
| Operating Income | -55.51M |
| Pretax Income | -63.12M |
| Net Income | -62.23M |
| EBITDA | -54.22M |
| EBIT | -55.95M |
| Loss Per Share | -$0.06 |
Balance Sheet
The company has $2.13 million in cash and $45.56 million in debt, giving a net cash position of -$43.43 million or -$0.04 per share.
| Cash & Cash Equivalents | 2.13M |
| Total Debt | 45.56M |
| Net Cash | -43.43M |
| Net Cash Per Share | -$0.04 |
| Equity / Book Value | -46.98M |
| Book Value Per Share | -0.04 |
| Working Capital | -41.08M |
Cash Flow
In the last 12 months, operating cash flow was -$53.64 million and capital expenditures -$3.44 million, giving a free cash flow of -$57.07 million.
| Operating Cash Flow | -53.64M |
| Capital Expenditures | -3.44M |
| Free Cash Flow | -57.07M |
| FCF Per Share | -$0.05 |
Margins
Gross margin is 10.30%, with operating and profit margins of -2,873.08% and -3,220.91%.
| Gross Margin | 10.30% |
| Operating Margin | -2,873.08% |
| Pretax Margin | -3,266.98% |
| Profit Margin | -3,220.91% |
| EBITDA Margin | -2,806.26% |
| EBIT Margin | -2,895.96% |
| FCF Margin | -2,954.14% |
Dividends & Yields
NWBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.74% |
| Shareholder Yield | -7.74% |
| Earnings Yield | -10.48% |
| FCF Yield | -9.62% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 26, 2012. It was a reverse split with a ratio of 1:16.
| Last Split Date | Sep 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
NWBO has an Altman Z-Score of -71.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -71.67 |
| Piotroski F-Score | 3 |